Alterations of the distal portion of the short arm of chromosome 1 (1p) are among the earliest abnormalities of human colorectal tumours. Recently, we have cloned the Aflatoxin B 1 aldehyde reductase (AFAR) gene from a smallest region of overlapping deletion that is frequently (48%) hemizygously deleted in sporadic colorectal cancer. AFAR is expressed in a broad range of tissues. Its closely related rat protein is the major factor conferring resistance of rats towards aflatoxin B 1 -induced liver carcinogenesis. Here, we have identified cDNAs covering two additional human AFAR-related genes localized in close proximity to the previously described AFAR at 1p35-36. We have analysed their structure and tissuerelated expression. One of them, AFAR3, carries a Selenocysteine-Insertion Element (SECIS)-like structure that during translation may recode an in-frame TGA-stop codon to a selenocysteine. Two additional AFAR-pseudogenes are localized at Xq25 and 1p12, respectively. AFAR exon sequences share an identity of DNA and amino acids of more than 78%. Also large blocks of intronic sequences can be up to 98.6% identical. Knowledge of the AFAR genes and their structure will be essential in genetic and functional studies, where discrimination of the genes and proteins is a prerequisite for evaluating their individual functions.
Introduction
Aflatoxin B 1 (AFB 1 ), which is produced by the mould Aspergillus flavus, is the most potent hepatocarcinogen known (Hengstler et al., 1999) . Carcinogenicity of AFB 1 , with interspecies differences in cancer susceptibility, has been reported for various species including rat, turkey, duck, trout and primates (Newberne and Butler, 1969; Hengstler et al., 1999) . The spectrum of tumours caused by aflatoxins is broad and includes, for instance, preneoplastic alterations in the colon of CF1 mice and Sprague-Dawley rats (Tudek et al., 1989) .
In Fischer 344 rats, carcinogenicity of AFB 1 is abrogated by antioxidants such as ethoxyquin (6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline; Ellis et al., 1993) . Cancer prevention results from the induction of detoxifying enzymes through ethoxyquin. The major enzyme providing protection against AFB 1 is the aflatoxin B 1 aldehyde reductase (AFAR), which reduces the dialdehyde form of AFB 1 to the dialcohol .
Searching for cancer-related genes at chromosome bands 1p35-36, a region frequently deleted in various tumours (Schwab et al., 1996) , led to the cloning of the human AFAR gene (Praml et al., 1998) . AFAR maps to a smallest region of overlapping deletion (SRO) in colorectal tumours (Praml et al., 1995) . Independently, AFAR was also cloned due to its homology with the R. norvegicus AFAR gene, and the encoded protein AFAR is capable of metabolizing various aldehydes and ketones (Ireland et al., 1998) . AFAR consists of seven exons encoding 330 amino acids with 78% identity to its homologous rat protein (Ireland et al., 1998; Praml et al., 1998) . The amino-acid sequences of the rat and human AFAR genes are less than 25% identical with other aldo-keto reductases, and they differ significantly in their substrate specificity from other reducing enzymes (Ellis and Hayes, 1995; Ireland et al., 1998; Praml et al., 1998) .
Several genes encoding detoxifying enzymes such as CYP1A1, CYP1A2, CYP2D6, GSTM1, GSTT1 and NAT2 act as low penetrance susceptibility genes in cancer (Houlston and Tomlinson, 2000) . We are pursuing the question whether mutated AFAR or allelic variants exist that might encode enzymes with different metabolic efficiencies influencing the individual cancer risk.
The broad expression of human AFAR in tissues such as heart, lung, liver, placenta, brain, colon, breast and others suggests that AFAR is not only involved in the metabolism of xenobiotic chemicals in the liver, but is likely to metabolize not yet identified genotoxic ketones and aldehydes from endogenous metabolic pathways. Examples for endogenous genotoxic aldehydes and ketones are catechol oestrogen-3,4-quinones and malondialdehyde (MDA; Cavalieri et al., 1997; Zhu and Conney, 1998; Marnett and Honn, 1994 ONCOGENOMICS from human brain that carries out the final step in the synthesis of the neuromodulator g-hydroxybutyrate (Schaller et al., 1999) . In this study, we present what appears to be the complete repertoire of human AFAR-related aldo-keto reductase genes of the AKR7 subfamily. This family seems to consist of three AFAR genes and two pseudogenes. The cloning, structural analysis, chromosomal localization and tissue-related expression analysis should provide a point of departure from which the further evaluation of AFAR genes as potential cancerrelated genes can proceed. In addition, we report the identification and sequencing of the first Afar homologue from mice, and a second from the rat.
Results
Our previous studies had established a contig of YACs, PACs and cosmids encompassing D1S199/PLA2G2A (Praml et al., 1998) . Cosmids I0231 and L19100 from this contig had been the basis for determining the complete sequence and structural organisation of the AFAR gene, referred to as AFAR1. By using the AFAR1 cDNA as a hybridization probe, we identified on highdensity colony filters additional cosmids and PACs, of which most localized to 1p35-36.1 by fluorescence in situ hybridization (FISH; data not shown), but did not match with the cosmids I0231 and L19100 in their PstI restriction patterns (Figure 1 ). This indicated the existence of at least one additional AFAR-related gene in the vicinity of AFAR.
Human AFAR-related genes AFARP1 The EST databases were searched for AFAR1 cDNA-related sequences, the clones were obtained from the Resource Center of the German Human Genome Project and sequenced. IMAGE clone 360588 (AA016040; AJ277796) from a human retina cDNA library was similar to the known full-length AFAR1 sequence. An (A) 8 G(A) 6 sequence starts at nucleotide 1248 with similarity of a poly(A) tail. Starting Figure 1 A physical map of the region encompassing AFAR1, AFAR2 and AFAR3 at 1p35-36.1. PACs and cosmids were digested and hybridized with terminal insert fragments (marker designations on top of the figure). The contig orientation is presented from distal (left) to proximal (right). AFAR primers used for sequencing are listed below, and the AFAR genes contained in the PACs and cosmids were evaluated from the electropherograms. The three AFAR genes are arrayed in tandem head to tail within an SRO for colorectal carcinoma Recently, Kelly et al. (2002) identified four human ESTs that had a 5 0 -extension in comparison with the AFAR1 cDNAs reported by Ireland et al. (1998) , Praml et al. (1998) and Schaller et al. (1999) . All four ESTs have a second upstream in-frame ATG start codon, usage of this start would result in an addition of 29 amino acids. The search of the EST databases revealed one previously unknown EST (BM543998) with this extension. However, of 83 ESTs of human AFAR1 with the originally described ORF, 78 lacked this additional start codon.
AFAR2 An attempt to amplify AFARP1 with the primers AFARP1.for13 and AFARP1.rev13 through RT-PCR from normal colon mucosa RNA led to the cloning and sequencing of an AFAR-related sequence 1162 bp in length, AFAR2, but no AFARP1 transcript was identified. The ORF of AFAR2 is defined by ATG start and TAG stop codons at nucleotides 8 and 1003, respectively (AJ271799). AFAR2 encodes 331 amino acids 87% identical with AFAR1, the polyadenylation signal AATAAA starts at nucleotide 1149.
AFAR3 While investigating if AFAR2 maps in the vicinity of AFAR1, PACs and cosmids that map to 1p35-36.1 were sequenced. Primer AFAR2.for7 (Figure 1 ) identified from cosmid P0629 an additional AFAR-related sequence, AFAR3, with homology to both the complete exon 7 and the untranslated 3 0 region of AFAR1. A search of the EST databases with this genomic AFAR3 sequence revealed additional AFARrelated ESTs. Pairwise alignment of each of more than 200 ESTs with the known full-length and partial AFARrelated sequences produced a single EST (AW050677) from a uterus (serous papillary carcinoma) cDNA library, IMAGE clone 2558079, identical to the genomic AFAR3 fragment. Further sequencing by primer walking revealed that exon 1 is missing in the clone, and a part of intron 1 is linked to the correctly spliced exons 2-7, followed by the 3 0 -untranslated region (946 bp of AFAR homology; AJ278012). A stop codon starts at nucleotide 780, and a polyadenylation signal at nucleotide 929.
Expression of the AFAR genes The spectrum of tissues and organs expressing AFAR1 was identified by regular database inspection and includes foetal thymus, bone marrow and tumours of the ovary, uterus, kidney and prostate, which were not reported earlier (Praml et al., 1998) . ESTs for AFAR2 were identified in the databases indicating that AFAR2 is not only expressed in colon but also in kidney, pancreas and adenocarcinoma of pancreas and endometrium. AFAR3 appears to be restricted to the uterus.
AFAR1, AFAR2 and AFAR3 in the physical map To determine if other AFAR genes besides AFAR1 map in the vicinity of AFAR1 at 1p35-36.1, we established a refined map by hybridizing STSs generated from the sequenced ends of the PAC and cosmid inserts to the PstI digested PACs and cosmids. Since all AFAR cDNAs cross-hybridize, the presence of each of the AFAR genes on the PACs and cosmids was verified by sequencing with AFAR-specific primers (Figure 1 ). Some primers specifically detected an individual AFAR gene. Other primers that cross-hybridized among the AFAR genes (AFAR2.for7) detected either an individual AFAR gene (P0629; AFAR3) or different ones (F0799; AFAR2 and AFAR3; Figure 2 ), depending on the PAC or cosmid sequenced. By combining the restriction digest patterns of PAC clones and sequencing all three AFAR genes were mapped at 1p35-36.1. The orientation appears in a head to tail tandem arrangement, distal-5 0 -AFAR1-AFAR2-AFAR3-3 0 -proximal.
AFAR pseudogenes at 1p12 and Xq25
The AFAR1 cDNA identified additional PACs on high-density hybridization filters that differed in their PstI restriction digest pattern from those PACs that mapped to 1p35-36.1. PACs P20229, N20229, I18228 and J036 belonged to one group, the AFARP1-specific F23178 to another. FISH localized F23178 to 1p12, all other clones to Xq25 (Figure 3 ). Comparing the sequences of the ends of the PACs with the databases, P20229sp6, N20229sp6 and J036sp6 identified an identical end-sequence from PAC RP4-562J12 (AC006965). With the availability of the complete RP4-562J12 sequence, a search for AFARrelated sequences revealed a pseudogene with 489% identity with the AFAR1 sequence. Two possible ATG start codons are at nucleotides 58347 and 58356, but only the latter corresponds to the start codon of AFAR1. The genomic sequence lacks introns and, compared with the AFAR1 cDNA, has insertions of 24, 2, 338 and 4 nucleotides, of which the latter three disrupt the reading frame. The largest insertion is highly homologous with repeats of the Alu-familiy. The TAG stop codon and the polyadenylation signal AATAAA are conserved. Altogether, Xq25 harbours a pseudogene referred to as AFARP2.
Allelic variants of mouse Afar1
The C57BL/6 and the BALB/c mouse differ in their metabolism and susceptibility to AFB 1 toxicity (Almeida et al., 1996) The AFAR family of aldo-keto reductases C Praml et al
Evolutionary conservation of AFAR genes The genomic structure of the human AFAR-genes is well conserved (Table 1) . Each of the three human genes consists of seven exons. All splice boundaries conform to the canonical GT/AG rule (Senapathy et al., 1990) . The human AFAR1-encoding gene is spread over 7.8 kbp, AFAR2 over 6.0 kbp and AFAR3 over 6.8 kbp. A BESTFIT DNA sequence comparison of AFAR1 (nt À201 from ATG/start to nt þ 49 from TAG/stop) with AFAR2 (nt À181 from ATG/start to nt þ 49 from TAG/stop) reveals 79.3% of identity over 8743 bp.
Comparison of AFAR2 (nt À1287 from ATG/start to nt þ 394 from TAG/stop) with AFAR3 (nt À1202 from ATG/start to nt þ 396 from TAA/stop) reveals 92.5% of identity over 8577 bp. Finally, comparison of AFAR1 (nt À58 from ATG/start to nt þ 59 from TAG/stop) with AFAR3 (nt À84 from ATG/start to nt þ 59 from TAA/stop) reveals 76.8% of identity over 8622 bp. These calculations underline, how much closer AFAR2 and AFAR3 are related to each other than to AFAR1. AFAR2-and AFAR3-encoding genes harbor an extended area of almost-identical sequence. The identity of local DNA sequence blocks can be as high as 98.6%, as can be calculated by comparing 719 bp of intronic DNA sequence directly 5 0 of both exons 7 of AFAR2 and AFAR3. Altogether, the data indicate that the AFAR/ AKR7 family arose from a common ancestral gene by repeated gene duplication events.
Further AFAR-related genes were identified by a combination of computer-assisted DNA-sequence comparisons and sequencing: Clone RMUBY49 (AI172371) contained a new full-length Afar-related gene, Afar2 (AJ271883), about 90% identical with human AFAR1. Additional homologous ESTs were identified from zebrafish (AW019754; 65% identity with AFAR1), Sus scrofa (F22965; 82.3%), Bos taurus (AW326461; 91%), and Neurospora crassa (AI392096; 58.7%), but not from other nonvertebrates.
AFAR3 contains a TGA stop codon and a SECIS-like element Computer-assisted translation of exons 2-7 of AFAR3 revealed a stop codon TGA at nucleotides 102-104 (AJ278012). Although this AFAR3-cDNA lacks the 5 0 end, AFAR3 has all characteristics of a functional gene since it is expressed, spliced and polyadenylated. One possibility is that the stop codon is suppressed through 'recoding', by which the stop codon is translated into the amino-acid selenocysteine (see; for reviews see Low and Berry, 1996; Gladyshev and Hatfield, 1999) . This process is directed by selenocysteine insertion sequence (SECIS) elements which are stem-loop structures of the RNA, in eukaryotes located in the 3 0 -untranslated (UTR) region. Eukaryotic SECIS elements typically share conserved nucleotides AUGA and AAA, separated by 12 nucleotides participating in a stem as shown for the rat type I thyroxine deiodinase (Dio1; X57999; Figure 4 ). In AFAR3, by employing the MFOLD computer program (Zuker and Stiegler, 1981) , a putative SECIS element is present. At nucleotides 418-421 we identified the AUGA sequence, at 435-437 the AAA sequence, separated by 13 bp predicted to be involved in a stem loop (Figure 4 ). In addition, the conserved nucleotides UG at 541-542 were predicted within a loop roughly opposite of the AUGA. AFAR3 contains all conserved features of a functional SECIS-element. The amino acids encoded by the SECIS element would be localized in the aldo-keto reductase loop B, a loop that appeared extended in the closely related rat Afar1 gene in comparison with other known functional aldo-keto reductases (Jez et al., 1997) . At this point we do not know if a cellular AFAR3 transcript would have an exon 1 like AFAR1, although the genomic structure is very similar (Table 1) . A possible AFAR3 protein needs yet to be identified.
Discussion
In this study, we present the repertoire of human AFARrelated aldo-keto reductase genes of the AKR7 subfamily. This family seems to consist of three AFAR genes and two pseudogenes. The AFAR family of aldo-keto reductases C Praml et al
Multiple AFAR genes are localized at 1p35-36
In addition to the previously known AFAR1 (Praml et al., 1998) gene, we have identified AFAR2 and AFAR3 at 1p35-36. The size of the three genes, their very similar organization and high homology up to near sequence identity for large DNA sequence blocks suggest that they have evolved from a common ancestor. The two AFAR-related sequences have obvious features of classical processed pseudogenes: They are intronless and have single or multiple frameshift mutations that can at best only result in a small peptide if at all translated. However, in case of AFARP1, the cDNA found in a human library may indicate a translational activity or genomic contamination which to distinguish is not easily possible. In contrast, AFAR3 that has introns like AFAR1 and AFAR2 and an in-frame TGA stop codon is clearly transcriptionally active shown by the identification of a processed transcript/cDNA. The even stronger homology between AFAR2 and AFAR3, particularly the much lower diversity within the introns of these two genes compared with AFAR1 suggests that these two genes arose through a much more recent duplication event during evolution. Recently, AFAR1 ESTs with a 5 0 -extension have been identified that harbour an alternative in-frame start codon (Kelly et al., 2002) . This raises the possibility that an AFAR1 variant exists which has additional Nterminal 29 amino acids. Similar extensions were also described in related mouse and rat ESTs, and a corresponding protein was detected in the rat. The fact that 94% (78 of 83) of the ESTs from databases with an open reading frame only have the originally described ATG start codon while 6% (five of 83) have the additional upstream ATG suggests that the majority of tissues expresses the originally described protein. Biochemical studies should answer the question as to what the role of the putative larger human variant might be.
A SECIS-like element may recode the TGA-codon to a selenocysteine
The SECIS-like element downstream of the TGA stop codon may recode the TGA codon in AFAR3 during translation to the amino acid selenocysteine, which works in the translation of at least 12 known selenoproteins (Gladyshev and Hatfield, 1999) . Alternatively, it may indicate that the protein has evolutionary ancestors with such function. The predicted energetical stability and the similarity of this structure with the typically conserved features of SECIS elements argue for a functional domain rather than random development. Still, three features are unique among the structure: The side branch, the localization within the coding region of the protein and the fact, that within the typical quartet AUGA there is Watson-Crick base pairing at the third position (G-C) instead of the typical non-Watson-Crick base pairing (Figure 4 ). It appears more likely that stem Figure 4 The secondary structure of the SECIS element of the rat type I thyroxine deiodinase (Dio1) gene (GenBank X57999; Berry et al., 1991) at left and of the putative SECIS element of human AFAR3 (right). Letters highlight conserved nucleotide regions typical for SECIS elements. The stem-loop structure was calculated using the MFOLD computer program (Zuker and Stiegler, 1981) The AFAR family of aldo-keto reductases C Praml et al loops form during evolutionary processes in the 3 0 -UTR of genes than in the coding regions, where a selection towards the perfect stem-loop structure might interfere with the function of the protein. Functional SECIS elements have been described in the coding region of bacterial selenoproteins, immediately downstream of the stop codon, but not in the coding region of eukaryotic genes, where their existence has been discussed (Low and Berry, 1996) . In addition, the branched structure of the AFAR3 SECIS-like element appears unique which may be due to evolutionary constrains to maintain protein function. The formation of the branch may stabilize the RNA structure indicated by a higher predicted release of free energy compared to the type I thyroxine deiodinase RNA structure. The localization of the SECIS-like element within loop B, which does not participate in the active centre of the enzyme, might also be a useful strategy not to interfere with the function. However, it has to be kept in mind that some of the structures were identified by computer algorithms because they fulfilled all the known criteria.
Mouse Afar alleles may confer susceptibility to AFB 1 Inbred mouse strains C57BL/6 are more susceptible than BALB/c mice to the acute toxic effects of AFB 1 (Almeida et al., 1996) . Such differences reflect each strain's ability to biotransform and eliminate AFB 1 and its metabolites. It may be interesting to determine, if the strain-specific differences of the Afar1 protein account for the metabolic differences observed, particularly, since only few genes participate in AFB 1 activation and detoxification. It is likely that such differences also affect tumour susceptibility. The sequences of MMU Afar1 alleles have been submitted to Genbank in January 2000 and are equivalent to the AFAR-related mouse gene identified by Hinshelwood et al. (2002) .
In apparent contradiction to the general chemoprevention of selenium in tumorigenesis (Garland et al., 1994; Clark and Alberts, 1995) , selenium-deficient rats are less susceptible to the toxic effects of AFB 1 (Chen et al., 1982) . The protection is associated with an increase of hepatic Afar1 and a glutathion S-transferase subunit (Gsta5; McLeod et al., 1997) . Here, the identification and study of a putative Afar selenoprotein might shed light on the pleiotropic effects of selenium.
Expression of human AFAR genes
The strong sequence conservation between the three AFAR genes makes it at least difficult to distinguish them by Northern blot analyses. It also complicates the generation of unique primers complementary to exons as well as to introns for PCR-amplification to investigate the sequence variation within these genes by SSCP analysis and genomic sequencing. Here, we have studied numerous ESTs from genome databases, to gain information about the expression pattern of AFAR genes. AFAR2 and AFAR3 expression appears more tissue-restricted than AFAR1, whose ESTs showed the broadest, probably ubiqitious, expression. Knowing the high homology of the AFAR genes and their potential to cross-hybridize under normal conditions, the analysis of ESTs seems more reliable to gain insight into expression patterns than earlier Northern analyses (Ireland et al., 1998; Knight et al., 1993) . For immunochemical and biochemical studies, only antibodies that discriminate between these enzymes are useful to evaluate their individual expression, localization and function.
Previously, anti-AFAR1 serum cross-reacted with a second rat liver Afar-related protein (Kelly et al., 2000) . In total, 16 amino acids from a peptide fragment of this protein were sequenced and matched the amino acid sequence that we predict for the rat Afar2 cDNA, but differed from rat Afar1 by two amino acids, therefore, both might be from the same gene. However, such a conclusion is not compelling since the existence of a further rat Afar-related gene is likely, that yet has to be identified. Afar2 is also identical with an androgeninducible aldehyde reductase gene, Aiar, in regrowing rat prostate (Nishi et al., 2000) . A recently reported AFB 1 metabolizing aldehyde reductase may be a different allele of AFAR2, since both encode proteins that only differ by one amino acid. The 3 0 UTR sequence of this reductase has not been fully determined earlier (Knight et al., 1999) .
Loss of AFAR genes at 1p35-36 may be a factor in tumorigenesis AFAR genes are organized in a multigene family locus in a region of frequent deletion in human sporadic colorectal tumours and many other cancers. In rats, Afar is the major enzyme providing protection against AFB 1 -induced hepatocarcinogenesis in Fischer 344 rats. To promote the detoxification by Afar, an induction of Afar by the antioxidant ethoxyquin is necessary (Ellis et al., 1993) . As previously proposed for AFAR1 (Praml et al., 1998) , also AFAR2, which is expressed in human colorectum, may be involved in colorectal carcinogenesis. Loss of heterozygosity might be responsible for a dosage effect, and/or different allelic variants may exist with different enzyme activity. Thus the detoxification of harmful endogenous aldehydes from metabolic pathways and possibly AFB 1 -metabolites may be (partially) impaired.
Recently, the crystal structure of the first Afar homologue, RNO Afar1, has revealed details of the binding of cofactors and substrate (Kozma et al., 2002) . This knowledge will be a valuable point of departure to investigate which of the structural differences account for the catalytical differences among members of the AFAR family. Also, functional analysis of in vitro mutagenized AFAR alleles should clarify if genetic polymorphisms among human populations are likely to encode proteins with different functions.
The AFAR family of aldo-keto reductases C Praml et al In summary, the elucidation of the set of human AFAR genes and their genomic structure as presented here will be valuable not only for future genetic studies, in which the genetic status in humans needs to be determined by sequencing, but also for the discrimination between the individual genes and proteins in functional studies in which their particular function must be evaluated. The identification of a SECIS-like structure can be helpful to find further potential selenoproteins by computerbased approaches once the human genome is fully known.
Materials and methods

Identification of PACs and cosmids
PACs were identified from library no. 704, cosmids from no. 112 of the Resource Center of the German Human Genome Project, Berlin (http://www.rzpd.de) using an AFAR-specific hybridization probe generated by reverse transcription-PCR with the primers AFAR.for and AFAR.rev from a colonic mucosa first strand cDNA preparation (Praml et al., 1998) .
Designations of clones from 1p35-36. Designation of the clone from 1p12 is: LLNLP704F23178Q14.
Identification of STS from PACs and cosmids for fingerprinting
To assemble a PAC and cosmid contig of the AFAR locus, additional STSs for fingerprinting were obtained by routinely sequencing the ends of the inserts. Sequencing was done with the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin Elmer) with AmpliTaq DNA Polymerase, FS, using a Gene Amp PCR System 2400 (Perkin Elmer) and an ABI PRISM 310 Genetic Analyzer.
Contig construction by Southern blot analysis
For fingerprinting by hybridization, DNA of PACs and cosmids was prepared using QIAGEN (Hilden, Germany) columns following the instructions supplied, digested with PstI and blotted onto a nylon membrane. Primer pairs derived from the ends of PAC and cosmid inserts were used to amplify hybridization probes that were labelled with [g-32 P]dCTP by random priming. The primers were not validated for PCR use with total genomic DNA as template.
The following PCR primers were used for the generation of locus-specific PCR probes: 
Contig contruction by DNA-sequence fingerprinting
For fingerprinting by sequencing primers were obtained from different parts of the AFAR1-3 cDNAs. The primers were used with different PAC-and cosmid DNAs, which were identified by Southern hybridization to carry AFARrelated sequences and which shared a related PstI restriction pattern, as a template for sequencing. The following primers were used: 
Probe labelling and FISH analysis
DNA was labelled by nick translation with biotin-14-dCTP (Life Technologies, Inc.). or DIG-11-dUTP (Roche Diagnostics Mannheim). Suppression of repetitive sequences, denaturation, hybridization and fluorescence detection were as described Savelyeva et al., 1994) . FITC-avidin (Vector Laboratories) and biotinylated antiavidin D (Vector) were used for detection of hybridized biotinylated DNA. Anti-DIG-mouse IgG1k (Roche Diagnostics Mannheim) and Cy3-conjugated sheep anti-mouse IgG (Dianova) were used to detect DIG-labeled probes. Slides were counterstained with 4 0 ,6-diamidino-2-phenylindole, mounted in antifade solution, and analysed with a Zeiss Axiophot microscope. Images were taken with a cooled charge-coupled device camera (KAF 1400; Photometrics) and processed using IPLab Spectrum software.
